China SXT Pharmaceuticals, Inc. (SXTC) › Gross ProfitChina SXT Pharmaceuticals, Inc. (SXTC) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2017: $2.31M2018: $3.40M2019: $4.61M2020: $2.70M2021: $2.84M2022: $1.25M2023: $426.3K2024: $554.0K2025: $367.4K$367.4K2017Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$367.4K-33.7%2024$554.0K+30.0%2023$426.3K-65.9%2022$1.25M-55.9%2021$2.84M+5.0%2020$2.70M-41.4%2019$4.61M+35.6%2018$3.40M+47.1%2017$2.31M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share